Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Zenas BioPharma, Inc.
13D/A
Amendment 2
ZBIO · 98937L105
|
4.9% |
8/19/2026
Event 8/19/2026
|
|||
| Enavate Sciences GP, LLC | 4.9% | ||||
| Zebra Aggregator, LP | 4.9% | ||||
|
CAMP4 Therapeutics Corporation
13D/A
Amendment 3
CAMP · 13463J101
|
4.8% |
3/11/2026
Event 3/9/2026
|
|||
| Enavate Sciences GP, LLC | 4.8% | ||||
| Everest Aggregator, LP | 4.8% | ||||
|
CAMP4 Therapeutics Corporation
13D/A
Amendment 2
CAMP · 13463J101
|
6.0% |
12/23/2025
Event 12/19/2025
|
|||
| Enavate Sciences GP, LLC | 6.0% | ||||
| Everest Aggregator, LP | 6.0% | ||||
|
Immunome, Inc.
13D/A
Amendment 2
IMNM · 45257U108
|
4.3% |
12/22/2025
Event 12/18/2025
|
|||
| Enavate Sciences GP, LLC | 4.3% | ||||
| Immunome Aggregator, LP | 4.3% | ||||
|
Zenas BioPharma, Inc.
13D/A
Amendment 1
ZBIO · 98937L105
|
7.3% |
10/14/2025
Event 10/9/2025
|
|||
| Enavate Sciences GP, LLC | 7.3% | ||||
| Zebra Aggregator, LP | 7.3% | ||||
|
CAMP4 Therapeutics Corporation
13D/A
Amendment 1
CAMP · 13463J101
|
8.1% |
9/15/2025
Event 9/11/2025
|
|||
| Enavate Sciences GP, LLC | 8.1% | ||||
| Everest Aggregator, LP | 8.1% | ||||
|
Sionna Therapeutics, Inc.
13D
SION · 829401108
|
5.6% |
2/18/2025
Event 2/10/2025
|
|||
| Enavate Sciences GP, LLC | 5.6% | ||||
| Sionna Aggregator, LP | 5.6% | ||||